These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6393495)

  • 1. [Raynaud's disease treated with captopril (Capoten). A randomized double-blind cross-over study].
    Madsen JL; Hvidt S
    Ugeskr Laeger; 1984 Sep; 146(36):2695-7. PubMed ID: 6393495
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of Capoten in systemic scleroderma].
    Guseva NG; Anikina NV; Shcherbakov AB
    Ter Arkh; 1992; 64(5):100-2. PubMed ID: 1455361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
    Rhedda A; McCans J; Willan AR; Ford PM
    J Rheumatol; 1985 Aug; 12(4):724-7. PubMed ID: 3903157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of captopril on cutaneous blood flow in patients with primary Raynaud's phenomenon.
    Rustin MH; Almond NE; Beacham JA; Brooks RJ; Jones DP; Cooke ED; Dowd PM
    Br J Dermatol; 1987 Dec; 117(6):751-8. PubMed ID: 3322358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Raynaud's syndrome with captopril].
    Trübestein G; Wigger E; Trübestein R; Ludwig M; Wilgalis M; Stumpe KO
    Dtsch Med Wochenschr; 1984 Jun; 109(22):857-60. PubMed ID: 6373219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nicardipine in the treatment of Raynaud's phenomenon].
    Kahan A; Amor B; Menkès CJ
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):487-90. PubMed ID: 3303287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.
    Rodeheffer RJ; Rommer JA; Wigley F; Smith CR
    N Engl J Med; 1983 Apr; 308(15):880-3. PubMed ID: 6339921
    [No Abstract]   [Full Text] [Related]  

  • 8. Double-blind randomized trial of nitroderm TTS in the treatment of Raynaud's phenomenon.
    Nahir AM; Schapira D; Scharf Y
    Isr J Med Sci; 1986 Feb; 22(2):139-42. PubMed ID: 3081460
    [No Abstract]   [Full Text] [Related]  

  • 9. DIAS rounds. Nifedipine and prazosin in Raynaud's phenomenon.
    Pisenti L; Hart LL
    Drug Intell Clin Pharm; 1984 Mar; 18(3):213-4. PubMed ID: 6365494
    [No Abstract]   [Full Text] [Related]  

  • 10. A double blind trial of UK-38,485, an orally active thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome.
    Rustin MH; Grimes SM; Kovacs IB; Cooke ED; Bowcock SA; Sowemimo-Coker SO; Turner P; Kirby JD
    Eur J Clin Pharmacol; 1984; 27(1):61-5. PubMed ID: 6386490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J
    Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
    [No Abstract]   [Full Text] [Related]  

  • 12. [A double-blind clinical trial of a topical preparation with a base of biochemical precursors of glucosaminoglycan (GAG) in patients suffering from Raynaud's disease].
    Signorini GP
    Boll Chim Farm; 1986 Oct; 125(10):103S-110S. PubMed ID: 3551995
    [No Abstract]   [Full Text] [Related]  

  • 13. Thymoxamine for Raynaud's disease and chilblains.
    Jaffe GV; Grimshaw JJ
    Br J Clin Pract; 1980; 34(11-12):343-6. PubMed ID: 6450602
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of nifedipine (Adalat) on Raynaud's phenomenon].
    Baadsgaard O; Schmidt JF; Ironmann L
    Ugeskr Laeger; 1983 Dec; 145(49):3814-6. PubMed ID: 6364517
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon.
    van der Meer J; Wouda AA; Kallenberg CG; Wesseling H
    Vasa Suppl; 1987; 18():71-5. PubMed ID: 3299819
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.
    Sauza J; Kraus A; González-Amaro R; Alarcón-Segovia D
    J Rheumatol; 1984 Jun; 11(3):362-4. PubMed ID: 6376801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of nifedipine in patients with Raynaud's phenomenon].
    Rozwodowska M; Polaszewska-Muszyńska M; Ukleja-Adamowicz M; Rewakowicz M; Guzowska M; Marunowska A; Jundziłł W; Wodyńska T; Ruchalski M; Strzelecki A
    Kardiol Pol; 1987; 30 Suppl():97-105. PubMed ID: 3331405
    [No Abstract]   [Full Text] [Related]  

  • 18. Raynaud's disease: a new therapeutic approach with a 5-HT2 receptors blocker.
    Allegra C; Tonelli V; Bonifacio M; Mari A; Assogna G
    Boll Chim Farm; 1985 Oct; 124(10):121S-124S. PubMed ID: 2935173
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of two beta-blocking drugs in patients with Raynaud's phenomenon.
    Holti G
    Practitioner; 1982 Apr; 226(1366):781-3. PubMed ID: 7045853
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicardipine in the treatment of Raynaud's phenomenon: a randomized double-blind trial.
    Kahan A; Amor B; Menkès CJ; Weber S; Guérin F; Degeorges M
    Angiology; 1987 Apr; 38(4):333-7. PubMed ID: 3555175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.